Oliver's Real Food tells market "no doubt" gains in shareholder value are coming

Will a rising share price be another missed forecast from Oliver's Real Foods?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Oliver's Real Food Limited (ASX: OLI) shares are down more than 75% since it listed at 20 cents per share in June 2017 after management missed a series of forecasts over the profitability of its healthy fast food chain.

In fact the group has mainly posted losses as a listed entity which is why investors have dumped the stock since the IPO.

On July 26 the company reported an operating cash loss of $527,000 for the quarter ending June 30,2019 with just $1.16 million cash on hand, but then just three days later put out a confusing announcement telling investors it had in fact posted positive EBITDAI of $161,000 for the quarter. 

Today it put out another unusual announcement to the ASX as its latest chairman boasted that it had enjoyed a strong start to FY 2020 and posted positive EBITDA for the month of August.

'With the company now generating positive cash flows, increasing with each successive quarter the board is now very confident that our profit result for FY2020 will be incredibly well received by the market," commented its chairman Nicholas Dover.

As if these forecasts were not enough the chairman appeared to claim there's "no doubt" the Oliver's share price is set to go up.

" There is no doubt that as the market continues to regain confidence in management and the board as we report a continuing improvement in all aspects of the company's performance, we will see further gains in shareholder value," Mr Dover commented in the announcement. 

Let's hope a rising share price isn't another missed forecast from a management team that has failed to impress as a listed entity so far. 

The stock closed up 9% to 4.7 cents today. 

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »